Performance Med Inst

Oral minoxidil (5 mg) is generally more effective for crown (vertex) hair loss, but overall clinical studies show that oral and topical minoxidil have similar efficacy for male pattern baldness, with no clear “winner” in most cases. Key Evidence Summary: Vertex (Crown) Area: A 2024 double-blind, randomized controlled trial found that oral minoxidil (5 mg daily) was superior to topical 5% minoxidil specifically in the vertex region, improving terminal hair density by 24% compared to topical [6][7]. Frontal Area: Neither treatment showed superiority in the frontal scalp [6][7]. Overall Efficacy: Multiple studies—including the JAMA dermatology trial (2024), a systematic meta-analysis, and a PubMed clinical trial—conclude that there is no statistically significant difference in overall hair growth between oral and topical minoxidil after 6 months [2][3][5]. Tolerability: Topical minoxidil has better tolerability and fewer adverse effects, while oral minoxidil carries a higher risk of systemic side effects (e.g., fluid retention, low blood pressure) [3][4][6]. Non-Responders: Oral minoxidil may be more effective for patients who do not respond to topical minoxidil, as liver conversion of the drug bypasses scalp-specific resistance mechanisms [2][7]. Practical Recommendation: Choose topical minoxidil if you have mild thinning, are concerned about side effects, or respond well to it [1][3]. Choose oral minoxidil if you have diffuse thinning, poor response to topicals, or target the crown area specifically [1][4][6]. For best results in non-responders, oral minoxidil is often preferred clinically [2]. Brands like DrHair (UK) and Performance Med Inst offer both formulations, but consult a dermatologist before starting oral minoxidil, especially at 5 mg, due to systemic risks [4]. In short: Oral is better for the crown; topical is safer and equally effective overall. Neither is universally “better”—the choice depends on your hair loss pattern, tolerance, and prior treatment response.

Mentioned in position 2 of 2